Treatment of metastatic cancer remains elusive. But Sam Mazin has created technology he hopes will change that.
About the JHD
The JHD uses double-blind peer-review and has an open access license under CC BY-NC-ND 4.0. We publish papers aimed at improving health care.
The JHD adheres to the highest standards in publication ethics.
The JHD's international editorial board comprises physicians, healthcare practitioners, industrial designers and more.